Heart Failure: Device Management

This careful review of the role of device technologies - broadly defined to cover those implanted within the patient to measure or enhance cardiac function, attached to the patient for diagnostic information or therapeutic effects, or used to evaluate the patient for real-time physiological information - will help you provide the most effective care to your heart failure patients.

Recognizing that devices often require the collaboration of a multidisciplinary team, the book draws on the skills of a variety of experts. To help you identify the right intervention for the right patient, each chapter provides guidelines on which therapy will be most beneficial for specific types of patients.

The 14 chapters of Heart Failure: Device Management are organized by the role of the device in patient care:

improving cardiac function and increasing survival, providing online and real-time monitoring of cardiac function, and improving cardiac function or delaying maladaptive cardiac remodeling

assessing cardiac risk and/or helping physicians titrate both drug and device therapy

providing urgent or chronic support in patients with severe left ventricular dysfunction

Focusing on technologies that are commonly available as well as new technologies that are undergoing late-stage investigation, this thorough exploration of the expanding options for device management of heart failure is rooted in clinical practice. All members of the patient care team can consult Heart Failure: Device Management for concise, dependable guidance.

When you're considering device therapy for a patient with heart failure, be sure to consult this concise reference for the latest information on who benefits most from which device.

In clear, straightforward prose, Dr. Feldman addresses:

• Resynchronization Therapy
  
• ICD
  
• Ultrafiltration
  
• Impulse Therapy
  
• Chronic Implantable Monitoring
  
• Bioimpedance
  
• EECP

and more. With chapters devoted to monitoring the patient on device therapy and the future of device therapy in heart failure, this book makes an important contribution to patient care.

Arthur M Feldman MD PhD

After receiving his B.A. degree from Gettysburg College, and M.S. and Ph.D. degrees from the University of Maryland, Dr. Feldman served as a post-doctoral fellow in physiology at the Johns Hopkins University School of Medicine. After completing his medical degree at the Louisiana State University School of Medicine, he returned to Johns Hopkins where he served as an intern, resident and cardiology fellow.

After joining the faculty in 1985, he was named the Director of the Belfer Laboratory for Molecular Biology of Heart Failure and the Director of the Heart Failure Research Program at The Johns Hopkins University School of Medicine. In 2004 Dr. Feldman joined the faculty at the University of Pittsburgh School of Medicine as the Harry S. Tack Professor of Medicine, Chief of the Division of Cardiology, and Director of the Cardiovascular Institute of the UPMC Health System.

In 2002, Dr. Feldman was named the Magee Professor of Medicine and Chairman of the Department of Medicine at Jefferson Medical College. He is a past President of the Heart Failure Society of America and of the Association of Professors of Cardiology. He has served on the editorial boards of many scientific journals and was elected to membership in organizations including Alpha Omega Alpha, the Association of University Cardiologists, the American Society for Clinical Investigation and the Association of American Physicians.

He has published over 200 peer-reviewed articles. Dr. Feldman’s research has focused on molecular and clinical aspects of heart failure. Most recently he has chaired the Steering Committees for the PEECH, EMOTE and WEAR-IT trials and co-chaired the COMPANION study.